LEPR and neoplasm: However, without estrogen signaling, it is attractive to speculate with the concept that tumor progression may be driven by other signaling factors such as fibroblast growth factor receptor-1 (FGFR-1), insulin growth factor 1 (IGF-1), or Ob-R [37,38].